Back
NLS Pharmaceutics Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
NLSP
NLS Pharmaceutics
Last Price:
$1.49
Seasonality Move:
-40.44%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing selling pressure, which indicates risk of future bearish movement.
NLS Pharmaceutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.49 | Sell |
20-day SMA: | 1.54 | Sell |
50-day SMA: | 1.83 | Sell |
200-day SMA: | 4.34 | Sell |
8-day EMA: | 1.5 | Sell |
20-day EMA: | 1.58 | Sell |
50-day EMA: | 1.85 | Sell |
200-day EMA: | 5.07 | Sell |
NLS Pharmaceutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 42.38 | Sell |
Chaikin Money Flow: | -12129 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.47 - 1.71) | Sell |
Bollinger Bands (100): | (1.53 - 3.01) | Sell |
NLS Pharmaceutics Technical Analysis
Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NLS Pharmaceutics Stock
Is NLS Pharmaceutics Stock a Buy?
-
NLS Pharmaceutics share price is 1.49 while NLSP 8-day simple moving average is 1.49, which is a Sell signal.
-
The stock price of NLSP is 1.49 while NLS Pharmaceutics 20-day SMA is 1.54, which makes it a Sell.
-
NLS Pharmaceutics 50-day simple moving average is 1.83 while NLSP share price is 1.49, making it a Sell technically.
-
NLSP stock price is 1.49 and NLS Pharmaceutics 200-day simple moving average is 4.34, creating a Sell signal.
NLSP Technical Analysis vs Fundamental Analysis
Sell
30
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy or a Sell?
-
NLS Pharmaceutics stock is rated a SellThe current NLS Pharmaceutics [NLSP] share price is $1.49. The Score for NLSP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
NLS Pharmaceutics Stock Info
Market Cap:
5.7M
Price in USD:
1.49
Share Volume:
16.6K
NLS Pharmaceutics 52-Week Range
52-Week High:
18.39
52-Week Low:
1.30
Sell
30
NLS Pharmaceutics (NLSP)
is a Sell
NLS Pharmaceutics Share Price Forecast
-
What is the NLS Pharmaceutics stock price today?The NLS Pharmaceutics stock price is 1.49 USD today.
-
Will NLSP stock go up or go down?NLS Pharmaceutics> share price is forecast to RISE/FALL based on technical indicators
-
Is NLS Pharmaceutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NLS Pharmaceutics is overvalued.
Is NLS Pharmaceutics Stock a Buy?
-
NLS Pharmaceutics share price is 1.49 while NLSP 8-day exponential moving average is 1.50, which is a Sell signal.
-
The stock price of NLSP is 1.49 while NLS Pharmaceutics 20-day EMA is 1.58, which makes it a Sell.
-
NLS Pharmaceutics 50-day exponential moving average is 1.85 while NLSP share price is 1.49, making it a Sell technically.
-
NLSP stock price is 1.49 and NLS Pharmaceutics 200-day simple moving average is 5.07, creating a Sell signal.
Technical Analysis of NLS Pharmaceutics
Should I short NLS Pharmaceutics stock?
-
NLSP Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting NLS Pharmaceutics is a Sell
-
NLS Pharmaceutics Relative Strength Index (RSI) is 42.38, which suggest NLS Pharmaceutics is oversold
-
The Bollinger Bands (25) for NLS Pharmaceutics is (1.47 - 1.71), which suggest NLS Pharmaceutics is a Sell
-
The Bollinger Bands (100) for NLS Pharmaceutics is (1.53 - 3.01), which suggest NLS Pharmaceutics is a Sell
* NLS Pharmaceutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.